VS

VCJ Staff

VC-Backed IPO Alert: Medidata Prices Above Range

2 min read · 25 June 2009

Fine Point Tech Buys Pervenio

Fine Point Technologies Inc., a New York-based provider of tools for broadband network connectivity management, has acquired Pervenio Ltd., a Cork, Ireland-based maker of wireless device detection and management solutions for mobile communications providers. No financial terms were disclosed. Fine Point has raised VC funding from Edison Venture Fund.

3 min read · 24 June 2009

TARIS Biomedical Raises $15 Million

TARIS Biomedical, a Lexington, Mass.-based drug/device convergence company formed by a team of MIT scientists, has raised $15 million in Series A funding. Backers include Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.

4 min read · 24 June 2009

Cytox Raises £600,000

Cytox Ltd., a UK-based provider of biomarker services for Alzheimer's disease clinical trials, has raised £600,000 in seed funding. Backers include MASA Life Sciences and Midven Ltd.

4 min read · 24 June 2009

AdMeld Adds $8 Million

AdMeld Inc., a New York-based provider of online advertising optimization and integration, has raised $8 million in Series B funding co-led by Foundry Group and Spark Capital. The two firms previously co-led AdMeld's $7 million Series A round.

3 min read · 24 June 2009

blueKiwi Software €4.7 Million

blueKiwi Software, a Paris, France-based provider of enterprise social software, has raised €4.7 million in second-round funding. Backers include Sofinnova Partners and Dassault Systèmes.

3 min read · 24 June 2009

SynCardia Systems Raises $10.3 Million

SynCardia Systems Inc., a Tuscan, Ariz.-based maker of artificial hearts that can serve as a birdge to human heart transplant for patients dying from end-stage biventricular failure, has raised $10.3 million in Series D funding. Highway 12 Ventures led the round, with managing partner Mark Solon taking a board seat.

3 min read · 24 June 2009

Intrexon Adds $10 Million

Intrexon Corp., a Blacksburg, Va.-based developer of biotherapeutic control systems, has raised $10 million in additional Series C-2 funding. The capital came from return backer New River Management, managed by Third Security LLC, which has now invested $66.5 million into Intrexon. The new infusion represents the final investment from NRM-V, but the firm will continue to support Intrexon out of NRM-VI.

3 min read · 24 June 2009

Fantzer Buys Mustache Inc.

1 min read · 23 June 2009

Setanta Sports Enters Administration

3 min read · 23 June 2009

Showing 7,301 to 7,310 of 12,104 results
1…730732…1000